Report cover image

South Korea Drug Delivery Devices Market, By Product Type (Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical, Others); By Application (Oncology, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases (CVDs), Autoimmun

Publisher BlueWeave Consulting
Published Oct 21, 2024
Length 123 Pages
SKU # BLWC19296795

Description

South Korea Drug Delivery Devices Market to Reach Value of USD 0.7 Billion by 2030

South Korea Drug Delivery Devices Market is flourishing because of rising healthcare spending and the government’s support to provide support to promote development and adoption of medical devices.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated South Korea Drug Delivery Devices Market size at USD 0.46 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects South Korea Drug Delivery Devices Market size to expand at a CAGR of 6.50% reaching a value of USD 0.70 billion by 2030. Growing elderly population, rising incidence of chronic illnesses, and growing emphasis on patient comfort and convenience are major growth factors for South Korea Drug Delivery Devices Market. In order to create efficient and cutting-edge drug delivery devices, businesses are heavily spending in pharmaceutical R&D, which is projected to propel the South Korea Drug Delivery Devices Market during the period in analysis.

Opportunity - Growing Prevalence of Chronic Diseases

The growing prevalence of various chronic diseases, including diabetes, heart disease, cancer, and chronic respiratory diseases, is emerging as the major driving factor for South Korea Drug Delivery Market. As a result, the need for long-term treatment of these health issues is rising in the country. The demand for drug delivery systems is increasing at a high rate for targeted drug delivery, boosting the efficacy of drugs and reducing toxicity. Targeted drug delivery methods frequently call for fewer doses or administrations, which can increase patient compliance and guarantee that medicine is taken as directed.

Impact of Escalating Geopolitical Tensions on South Korea Drug Delivery Devices Market

Escalating geopolitical tensions could negatively impact the growth of South Korea Drug Delivery Devices Market. The Drug Delivery Devices Market in South Korea is disrupted by geopolitical tensions and wars, which results in a lack of raw materials and components and a spike in price. The market depends a great deal on imports of important items and components in drug delivery devices. However, trade constraints, like sanctions, might force domestic and international pharmaceutical companies operating to coordinate their operations with the new regulatory standards. This could result in a slower rate of market introduction for new products.

Diagnostic Centers Segment to Register Fastest CAGR

During the forecast period, the diagnostic centers segment is expected to grow at the fastest CAGR in South Korea Drug Delivery Devices Market by end user. Drug delivery devices are used in diagnostic centers to deliver drugs in a controlled and targeted manner for various purposes, including prevention of STIs and pregnancy, treatment of tuberculosis (TB), and others. The other major end user segments in South Korea Drug Delivery Devices Market include hospitals, ambulatory surgery centers/clinics, and home care settings.

Competitive Landscape

South Korea Drug Delivery Devices Market is intensely competitive, as a number of companies are competing to gain a significant market share. Key players in the market include Bayer, Baxter International, GlaxoSmithKline, 3M Company, Pfizer Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co., Novartis AG, and Quad Medicine.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and South Korea Drug Delivery Devices Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in South Korea Drug Delivery Devices Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

123 Pages
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. South Korea Drug Delivery Devices Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Rising aging population in South Korea
3.2.1.2. Rising healthcare spending
3.2.1.3. Government support to provide support to promote development and adoption of medical devices
3.2.2. Restraints
3.2.2.1. High manufacturing costs
3.2.2.2. Limited domestic manufacturing capabilities
3.2.3. Opportunities
3.2.3.1. Innovations in drug delivery technologies
3.2.3.2. Growing demand for personalized medicine
3.2.3.3. Government support for innovation
3.2.4. Challenges
3.2.4.1. Shortage of skilled professionals in drug delivery devices
3.2.4.2. Strict environmental regulations
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. South Korea Drug Delivery Devices Market: Marketing Strategies
5. South Korea Drug Delivery Devices Market: Pricing Analysis
6. South Korea Drug Delivery Devices Market Overview
6.1. Market Size & Forecast, 2019–2030
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.1.1. Oral
6.2.1.2. Inhalation
6.2.1.3. Transdermal
6.2.1.4. Injectable
6.2.1.5. Ocular
6.2.1.6. Nasal
6.2.1.7. Topical
6.2.1.8. Others
6.2.2. By Application
6.2.2.1. Oncology
6.2.2.2. Infectious Diseases
6.2.2.3. Respiratory Diseases
6.2.2.4. Diabetes
6.2.2.5. Cardiovascular Diseases (CVDs)
6.2.2.6. Autoimmune Diseases
6.2.2.7. Central Nervous System (CNS) Disorders
6.2.2.8. Others
6.2.3. By End User
6.2.3.1. Hospitals
6.2.3.2. Diagnostic Centers
6.2.3.3. Ambulatory Surgery Centers/Clinics
6.2.3.4. Home Care Settings
6.2.3.5. Others
7. Competitive Landscape
7.1. List of Key Players and Their Offerings
7.2. South Korea Drug Delivery Devices Company Market Share Analysis, 2023
7.3. Competitive Benchmarking, By Operating Parameters
7.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
8. Impact of Escalating Geopolitical Tensions on South Korea Drug Delivery Devices Market
9. Company Profiles (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
9.1. Bayer
9.2. Baxter International
9.3. GlaxoSmithKline
9.4. 3M Company
9.5. Pfizer Inc.
9.6. F. Hoffmann-La Roche AG
9.7. Johnson & Johnson
9.8. Merck & Co.
9.9. Novartis AG
9.10. Quadmedicine
9.11. Other Prominent Players
10. Key Strategic Recommendations
11. Research Methodology
11.1. Qualitative Research
11.1.1. Primary & Secondary Research
11.2. Quantitative Research
11.3. Market Breakdown & Data Triangulation
11.3.1. Secondary Research
11.3.2. Primary Research
11.4. Breakdown of Primary Research Respondents
11.5. Assumption & Limitation
* Financial information of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
List of Figures
Figure 1 South Korea Drug Delivery Devices Market Segmentation
Figure 2 South Korea Drug Delivery Devices Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2023
Figure 4 South Korea Drug Delivery Devices Market Size, By Value (USD Million), 2019–2030
Figure 5 South Korea Drug Delivery Devices Market Share, By Product Type, By Value (USD Million), 2019–2030
Figure 6 South Korea Drug Delivery Devices Market Share, By Application, By Value (USD Million), 2019–2030
Figure 7 South Korea Drug Delivery Devices Market Share, By End User, By Value (USD Million), 2019–2030
List of Tables
Table 1 South Korea Drug Delivery Devices Market Size, By Value (USD Million), 2019–2030
Table 2 South Korea Drug Delivery Devices Market Share, By Product Type, By Value (USD Million), 2019–2030
Table 3 South Korea Drug Delivery Devices Market Share, By Application, By Value (USD Million), 2019–2030
Table 4 South Korea Drug Delivery Devices Market Share, By End User, By Value (USD Million), 2019–2030
Table 5 Bayer Company Overview
Table 6 Bayer Financial Overview
Table 7 Baxter International Company Overview
Table 8 Baxter International Financial Overview
Table 9 GlaxoSmithKline Company Overview
Table 10 GlaxoSmithKline Financial Overview
Table 11 3M Company: Company Overview
Table 12 3M Company Financial Overview
Table 13 Pfizer Inc. Company Overview
Table 14 Pfizer Inc. Financial Overview
Table 15 F. Hoffmann-La Roche AG Company Overview
Table 16 F. Hoffmann-La Roche AG Financial Overview
Table 17 Johnson & Johnson Company Overview
Table 18 Johnson & Johnson Financial Overview
Table 19 Merck & Co. Company Overview
Table 20 Merck & Co. Financial Overview
Table 21 Novartis AG Company Overview
Table 22 Novartis AG Financial Overview
Table 23 Quadmedicine Company Overview
Table 24 Quadmedicine Financial Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us